Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Suspected cancer: recognition and referral

NICE guideline
Reference number: NG12
Published: 23 June 2015
Last updated: 02 October 2023

History

Equality and health inequalities

Equality and health inequalities assessment (MSWord 56 KB)

Published:

24 August 2023

Guidance published

Committee member list (PDF 120 KB)

Published:

15 December 2021
Consultation comments and responses (PDF 1.03 MB)

Published:

15 December 2021
Equality impact assessment 4 (PDF 147 KB)

Published:

15 December 2021

Draft guidance consultation

Draft guidance consultation
Evidence review NG131 (PDF 1.82 MB)

Published:

21 October 2021
Evidence review NG12 (PDF 3.53 MB)

Published:

21 October 2021
Equality impact assessment 3 (PDF 172 KB)

Published:

21 October 2021
Committee member list (PDF 120 KB)

Published:

21 October 2021
Comments form (MSWord 40 KB)

Published:

21 October 2021
Draft guideline NG131 (PDF 421 KB)

Published:

21 October 2021
Draft guideline NG12 (PDF 209 KB)

Published:

21 October 2021

Stakeholder list updated

Stakeholder list (PDF 220 KB)

Published:

14 December 2021

Committee list updated

Committee member list (PDF 120 KB)

Published:

06 October 2021

Declaration of interests

Register of interests (PDF 398 KB)

Published:

14 December 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 433 KB)

Published:

08 September 2021
Minutes 2 (PDF 182 KB)

Published:

15 September 2021
Minutes Post-consultation (PDF 180 KB)

Published:

15 November 2021

Scope published

Final scope (PDF 252 KB)

Published:

18 August 2021

Update on 15 December 2021

Guidance published
Consultation comments and responses (PDF 1.03 MB)

Published:

15 December 2021
Committee member list (PDF 120 KB)

Published:

15 December 2021
Equality impact assessment 4 (PDF 147 KB)

Published:

15 December 2021
Draft guidance consultation
Draft guidance consultation
Evidence review NG131 (PDF 1.82 MB)

Published:

21 October 2021
Evidence review NG12 (PDF 3.53 MB)

Published:

21 October 2021
Equality impact assessment 3 (PDF 172 KB)

Published:

21 October 2021
Committee member list (PDF 120 KB)

Published:

21 October 2021
Comments form (MSWord 40 KB)

Published:

21 October 2021
Draft guideline NG131 (PDF 421 KB)

Published:

21 October 2021
Draft guideline NG12 (PDF 209 KB)

Published:

21 October 2021
Stakeholder list updated
Stakeholder list (PDF 220 KB)

Published:

14 December 2021
Committee list updated
Committee member list (PDF 120 KB)

Published:

06 October 2021
Declaration of interests
Register of interests (PDF 398 KB)

Published:

14 December 2021
Scope published
Final scope (PDF 252 KB)

Published:

18 August 2021
Committee meeting
Minutes 1 (PDF 433 KB)

Published:

08 September 2021
Minutes 2 (PDF 182 KB)

Published:

15 September 2021
Minutes Post-consultation (PDF 180 KB)

Published:

15 November 2021

Original development on 23 June 2015

Surveillance consultation
Surveillance consultation
Surveillance review proposal (online version)
Surveillance review proposal (PDF version) (PDF 277 KB)

Published:

11 May 2022
Supporting evidence (PDF 496 KB)

Published:

11 May 2022
Stakeholder list updated
Stakeholder list (PDF 128 KB)

Published:

10 May 2022
Surveillance consultation
Surveillance consultation
Comments form (MSWord 29 KB)

Published:

31 October 2019
Surveillance review proposal (PDF 630 KB)

Published:

31 October 2019
Committee meeting: 17
Minutes 17 (PDF 73 KB)

Published:

10 March 2016
Guideline consultation table with responses
Guideline consultation table with responses (PDF 2.63 MB)

Published:

23 June 2015
Recommendations equalities impact assessment form
Recommendations equalities impact assessment form (PDF 97 KB)

Published:

17 March 2015
Guideline consultation
Guideline consultation information
Costing report (PDF 323 KB)

Published:

24 November 2014
Appendices information
Appendices part 1 information
Appendices part 1 (PDF 4.54 MB)

Published:

24 July 2015
Appendices part 2 information
Appendices part 2 (PDF 8.19 MB)

Published:

20 November 2014
Appendices part 3 information
Appendices part 3 (PDF 8.31 MB)

Published:

20 November 2014
Appendices part 4 information
Appendices part 4 (PDF 9.01 MB)

Published:

20 November 2014
Draft NICE guideline (PDF 863 KB)

Published:

24 July 2015
Draft guideline (PDF 3.47 MB)

Published:

20 November 2014
Health economic plan review questions and search strategies
Health economic plan review questions and search strategies
Health economic plan (PDF 86 KB)

Published:

09 October 2014
Clinical questions information
Search strategies (PDF 2.16 MB)

Published:

09 October 2014
Suspected cancer: guideline development and consultation
Suspected cancer: guideline development and consultation
Stakeholder list - 23 December 2014 (PDF 177 KB)

Published:

23 December 2014
GDG members (PDF 19 KB)

Published:

24 July 2015
Suspected cancer: GDG minutes
Referral for suspected cancer: sixteenth GDG minutes - 1 and 2 September 2014 (PDF 90 KB)

Published:

16 February 2015
Referral for suspected cancer: fifteenth GDG minutes - 16 and 17 July 2014 (PDF 91 KB)

Published:

16 February 2015
Referral for suspected cancer: fourteenth GDG minutes - 3 and 4 June 2014 (PDF 178 KB)

Published:

25 September 2014
Referral for suspected cancer: thirteenth GDG minutes - 22 and 23 April 2014 (PDF 18 KB)

Published:

25 September 2014
Referral for suspected cancer: twelfth GDG minutes - 23 and 24 March 2014 (PDF 31 KB)

Published:

25 September 2014
Referral for suspected cancer: eleventh GDG minutes - 27 and 28 January 2014 (PDF 95 KB)

Published:

17 April 2014
Referral for suspected cancer: tenth GDG minutes - 25 and 26 November 2013 (PDF 97 KB)

Published:

17 April 2014
Referral for suspected cancer: ninth GDG minutes - 3 and 4 October 2013 (PDF 94 KB)

Published:

17 April 2014
Referral for suspected cancer: eighth GDG minutes - 4 September 2013 (PDF 96 KB)

Published:

17 April 2014
Referral for suspected cancer: sixth GDG minutes - 23-24 July 2013 (PDF 77 KB)

Published:

08 August 2013
Referral for suspected cancer: fifth GDG minutes - 5-6 March 2013 (PDF 95 KB)

Published:

08 August 2013
Referral for suspected cancer: fourth GDG minutes - 12 Dec 2012 (PDF 94 KB)

Published:

08 August 2013
Referral for suspected cancer: third GDG minutes - 17 Sept 2012 (PDF 91 KB)

Published:

08 August 2013
Referral for suspected cancer: second GDG minutes - 24 July 2012 (PDF 94 KB)

Published:

24 December 2012
Referral for suspected cancer: first GDG minutes - 19 and 20 June 2012 (PDF 109 KB)

Published:

24 December 2012
Suspected cancer: scoping workshop, consultation and final scope
Suspected cancer: scoping workshop, consultation and final scope
Suspected cancer: scoping equalities impact assessment form (PDF 30 KB)

Published:

14 August 2012
Suspected cancer: scope consultation table with responses (PDF 620 KB)

Published:

15 June 2012
Suspected cancer: final scope (PDF 121 KB)

Published:

15 June 2012
Suspected cancer: scope consultation information
Suspected cancer: draft scope (PDF 91 KB)

Published:

03 April 2012
Stakeholder list - 23 December 2014 (PDF 177 KB)

Published:

23 December 2014